AstraZeneca PLC (NASDAQ:AZN) is one of the best performing pharma stocks in 2025. On January 7, Berenberg Bank reiterated a ...
Walmart (WMT) is set to join the Nasdaq-100 Index before the market opens on Jan. 20, 2026, replacing the Anglo-Swedish ...
The key drivers of increased investor interest in AstraZeneca are the strong performance of its oncology and cardiovascular ...
Zacks Investment Research on MSN
Here's why AstraZeneca (AZN) is a strong momentum stock
It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different ...
If you are wondering whether AstraZeneca shares still offer fair value after a strong run, or if you might be paying too much for the story, this article is designed to help you frame that question ...
BostonGene has entered a new collaboration with AstraZeneca to apply its foundation AI model to oncology drug development, aiming to improve early trial decision-making around safety, efficacy, and ...
AstraZeneca’s new head of Investor Relations, Joris Silon, succeeds Andy Barnett on 1 March 2026, and will be based in ...
Nasdaq said Walmart Inc (NYSE:WMT) will join the Nasdaq-100 Index and a set of related benchmarks on Jan. 20, 2026, replacing AstraZeneca, in a change that ...
Detailed price information for Astrazeneca Plc ADR (AZN-Q) from The Globe and Mail including charting and trades.
AstraZeneca (AZN) announced an update on their ongoing clinical study.
AstraZeneca on Thursday appointed company insider Rick Suarez as the head of its U.S. biopharmaceuticals unit to lead the ...
Over 3.4 million people globally are affected by SLE, and it is one of the leading causes of death in young women in the US ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results